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The acquisition of terminal cell fate and onset of differentiation are instructed by cell type–specific master control
genes. Loss of differentiation is frequently observed during cancer progression, but the underlying causes and
mechanisms remain poorly understood. We tested the hypothesis that master regulators of differentiation may be key
regulators of tumor formation. Using loss- and gain-of-function analyses in Drosophila, we describe a critical anti-
oncogenic function for the atonal transcription factor in the fly retina, where atonal instructs tissue differentiation. In
the tumor context, atonal acts by regulating cell proliferation and death via the JNK stress response pathway.
Combined with evidence that atonal’s mammalian homolog, ATOH1, is a tumor suppressor gene, our data support a
critical, evolutionarily conserved, function for ato in oncogenesis.
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Introduction
Cell fate commitment in neural and neuroendocrine
lineages of the peripheral nervous system (PNS) as well as
secretory epithelia is controlled by genes of the basic helix-
loop-helix (bHLH) superfamily of transcription factors. One
of the most structurally and functionally conserved groups
within this family is the Atonal (Ato) group proteins [1,2].
Drosophila ato (CG7508) and mammalian ATOH1 (Ensembl
accession number: ENSG00000172238) are required for cell
fate speciﬁcation and the induction of differentiation in the
PNS and the secretory lineages in all animal species. In
Drosophila, ato is necessary for cell fate speciﬁcation and
differentiation of mechano- and photoreceptors [3–5].
The acquisition of differentiated cell fate endows cells with
two key features. First, it allows them to become distinct from
one another and, accordingly, functionally specialized.
Second, it inhibits further cell division under physiological
conditions, thus controlling tissue size. When the regulation
of cell division fails, cancer may develop. Cancer, however, is
the result of a selective process in which cells accumulate
several genetic and epigenetic mutations giving them a
growth advantage over surrounding cells by, for example,
the inhibition of apoptosis, induction of angiogenesis, and
growth factor–independent survival [6]. More than one
mutation is needed for cancer to arise, and it is therefore
thought that mutations occur in undifferentiated cells that
are proliferative. As such, oncogenesis might select for cells
that have lost their capacity to induce differentiation. In this
context, it has been a long-standing postulate that cancer is a
disease of loss of differentiation [7,8]. Work in the seventies
and eighties by Harris and colleagues shows that hybrids of
malignant and diploid cells only become malignant again
after losing chromosomal loci required for differentiation
(e.g., [9]). More recently, the interplay between differentiation
and cancer has gained renewed attention through the study
of a pool of undifferentiated cells in tumors, the so-called
cancer stem or tumor-initiating cells [10]. A major theme
e m e r g i n gf r o mt h e s es t u d i e si st h ei m p o r t a n c eo ft h e
maintenance of an undifferentiated state in this niche for
tumor growth to occur. Furthermore, the fact that signals
implicated in regulating differentiation across various line-
ages, such as the WNT and Notch pathways, also have been
implicated both in the promotion and suppression of cancer
[11,12] suggests a mechanistic link between the regulation of
differentiation and tumor progression. Importantly, however,
these pathways are also implicated in stem cell or progenitor
cell maintenance and do not act in a lineage-restricted
fashion. As such, the deﬁnition of their role in tumor
progression vis-a-vis differentiation is unclear. For this
hypothesis to be correct, at least one key prediction should
hold true: master control genes that instruct cell fate
commitment in speciﬁc lineages should act as brakes on the
oncogenic process, either by preventing uncontrolled pro-
liferation or by inducing cell death when a differentiated
state can no longer be maintained. Thus, we hypothesize that
such master control genes suppress both tumor formation
and progression.
To test this prediction in lineages in which ato is the key
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PLoS BIOLOGYregulator of cell fate commitment, we asked two experimental
questions. First, does ato loss of function contribute to tumor
initiation or progression in tissues where ato instructs
differentiation, such as the Drosophila retina? Second, can
ato gain of function inhibit the formation or progression of
these tumors? Finally, we examined the genetic pathway by
which ato suppresses tumor formation.
We ﬁnd that loss of ato strongly enhances the formation
and progression of tumors in ﬂies. Conversely, gain of ato
function strongly inhibits tumor formation and metastasis.
Finally, we describe a highly conserved anti-oncogenic
genetic pathway that links ato activity to the stress sensor
Jun N-terminal kinase (JNK) pathway. Combined with genetic
and molecular evidence from mouse and human cancer
models [13], these data support a key role for ato in a very
e a r l ys t e po ft h eo n c o g e n i cp r o c e s sa n ds u g g e s tt h a t
mutations in master control genes of cell fate commitment
may be pivotal switches during tumorigenesis.
Results
Gain and Loss of ato Function Suppresses and Enhances
Tumor Formation, Respectively, in a Drosophila Cancer
Paradigm
We took advantage of the genetic power of Drosophila
melanogaster to investigate whether the gain and loss of
function of Drosophila ato suppresses and enhances tumor
formation, respectively. ato instructs differentiation in the
Drosophila eye [4]. We therefore turned to a well-established in
vivo eye cancer model, namely ‘‘eyeful’’ ﬂies, which has been
used to study the mechanisms of Rb and the PTEN-AKT
pathway in cancer [14,15]. The eyeful ﬂies have activated
Notch signaling in the developing eye due to overexpression
of the Notch ligand Delta (Dl, CG3619), combined with
overexpression of lola (CG12052) and psq (CG2368). Flies
overexpressing only Dl, leading to an increase in eye size but
no tumors, will henceforth be called ‘‘sensitized’’ ﬂies.
To analyze the tumor burden, each eye was scored
separately. Eyes were counted as hyperplastic when the eye
showed at least one fold. Metastasis can be seen as masses of
amorphous red-pigmented cells outside of the eye ﬁeld and
are observed on the head and in the thorax and abdomen
(Figure 1J–1L). Consistent with previous data, eyeful ﬂies
display excessively enlarged eyes, and eye tumors occur in
57% of the eyes, with 3% of the ﬂies showing macroscopically
visible metastases derived from the developing retina (n¼102;
Figures 1A, 1I, S1A, and S1B). Overexpression of ato, or its
mouse ortholog Atoh1 (Ensembl: ENSMUSG00000073043)—
but not a green ﬂuorescent protein (GFP) control transgene—
in the eyeful background almost completely suppresses the
formation of eye tumors (Figure 1B (ato): 2%, p , 0.0001, n ¼
118; Figure 1C (Atoh1): 1%, p , 0.0001, n ¼ 98; GFP
(unpublished data): p ¼ 0.25; Figure 1I). More importantly,
reduction of endogenous ato expression in the eye using an
ato RNA interference (RNAi) construct (a kind gift from A.
Jarman), which leads to loss of differentiated eye tissue in
wild-type ﬂies (Figure S2B), results in a dramatic increase in
both tumor incidence (90%, p , 0.0001, n ¼ 165; Figure 1D
and 1I) and the number of ﬂies with metastases (17%, p ¼
0.0003). These effects were not due to the overexpression of a
double-stranded RNA, per se, because the expression of an
RNAi construct for GFP did not change the tumor burden
(unpublished data; tumors: p ¼ 0.59, metastasis: p ¼ 0.21).
Since Ato is known as a transcriptional activator, we asked
whether its role in eye tumors is mediated by its ability to
activate gene expression. We constructed a repressor form of
Ato by fusing it to an Engrailed repressor domain (Ato
ERD)
[16]. Expression of Ato
ERD in the developing eye leads to loss
of differentiated eye tissue mimicking ato loss-of-function
mutations and the ato
RNAi construct (Figure S2A–S2C).
Expression of Ato
ERD in eyeful ﬂies results in both the loss
of differentiated eye tissue in 30% of the eye ﬁelds (Figure 1J,
open arrow), as well as in 100% tumors in the remaining eyes
(p , 0.0001, n ¼ 48; Figure 1E and 1I). Importantly, these
tumors include large patches of undifferentiated tissue,
showing that loss of ato’s differentiation function is linked
to its anti-oncogenic function (Figure 1E and 1M, dotted
line). Expression of Ato
ERD in the eyeful ﬂies also results in
75% of the ﬂies showing metastasis (Figure 1J, black arrow,
and Figure 1I; p , 0.0001). These data suggest that ato is a key
regulator of tumor progression in Drosophila and that it may
perform this function by regulating the differentiation status
of the transformed tissue.
Ato Acts as a Switch for Tumor Initiation
Loss of ato in a wild-type background abrogates retinal
differentiation and causes subsequent loss of the entire tissue
[4]. If loss of differentiation is an early causal event in cancer,
a key anti-oncogenic role for ato requires that its loss act as a
switch for tumor initiation in a pre-oncogenic background.
To this end, we used the sensitized genetic background that
was used to generate the eyeful model, namely eye-speciﬁc Dl
overexpression [14]. This genotype results in an increase in
proliferation, leading in turn to a slight overgrowth of the
eye, but no tumors are observed (n ¼ 478; Figure 1F) [17].
Inhibition of ato function by Ato
ERD leads, as it does in wild-
type ﬂies, to loss of retinal differentiation (36% of the eye
ﬁelds, empty arrow, Figure 1L), and to a 9% de novo tumor
incidence in the remaining eye ﬁelds (p , 0.0001, n ¼ 76;
Figure 1H, 1L, and 1L9), with 6% of the ﬂies showing
metastasis (p¼0.0003). Similarly, ato knockdown using ato
RNAi
in this sensitized background leads to eye tumors in 0.5% of
the eyes (p ¼ 0.0333, n ¼379; Figure 1G and 1K), and 0.3% of
the ﬂies have metastasis (p ¼ 0.1953). The metastases in the
sensitized ﬂies upon loss of ato function are mostly present in
the thorax and on the head. The metastases on the head
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Author Summary
During embryonic development, cells become more and more
specialized, and this process is referred to as differentiation. In
contrast to normal adult cells, cancer cells—like embryonic cells—
display fewer differentiated properties. It has been postulated that
the acquisition of terminal differentiation helps inhibit tumor
formation; however, no direct evidence for this hypothesis was
available. The development of the eye in the fruit fly, Drosophila
melanogaster, has long been used as a model for studying genetic
factors controlling differentiation. More recently, eye development
has also been used to study how tumors can form and progress. In
this study, we used this model to show that genes, such as atonal,
that instruct the differentiation of specific tissues can act as tumor
suppressers and inhibit the formation and progression of tumors in
those tissues. Losing such genes can generate tumors, whereas
activating them can strongly inhibit these tumors.Figure 1. atonal Gain and Loss of Function Suppress and Promote Tumor Formation, Respectively, in a Drosophila Cancer Paradigm
(A–I) Qualitative and quantitative representation of the tumor burden in different genotypes. Each lane is a separate genotype. Gray bars show
percentage of tumorous eyes, pie charts show metastasis incidence. (A) ey-GAL4, UAS-Dl, eyeful/
þ fly (‘‘
þ’’ ¼ wild-type chromosome). (B and C) Gain
of ato function suppresses tumor formation. (B) ey-GAL4, UAS-Dl, eyeful/UAS-ato. (C) ey-GAL4, UAS-Dl, eyeful/UAS-Atoh1. (D and E) Loss of ato function
enhances tumor burden. (D) ey-GAL4, UAS-Dl, eyeful/
þ; UAS-ato
RNAi/
þ. (E) ey-GAL4, UAS-Dl, eyeful/UAS-ato
ERD. Dotted line indicates undifferentiated
overgrowth of the eye tumor. (F) A sensitized genotype with eye-specific Dl overexpression leading to mild eye overgrowth: ey-Gal4, UAS-Dl/
þ.( G
and H) Loss of ato function can initiate tumor formation. (G) ey-Gal4, UAS-Dl/
þ, UAS-ato
RNAi/
þ. (H) ey-Gal, UAS-Dl/UAS-ato
ERD.
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RNAi ¼ 75%; ato
ERD ¼ 43%) show a high resemblance to
ectopically induced eyes as seen by Kurata and colleagues
upon overactivation of Notch signaling [18]. The loss of ato
might increase Notch signaling and as such interfere with
patterning and determination. We note, however, that we
never see any head metastasis when overexpressing Dl,
indicating that loss of ato creates new phenotypes including
the metastasis in the thorax, which cannot be explained by an
increase in Notch activity alone. In either case, these data
support the hypothesis that loss of ato function is sufﬁcient to
transform a sensitized lesion into a metastatic tumor, possibly
by interfering with patterning and determination.
Ato Regulates Apoptosis and Proliferation in Drosophila
Eye Tumors
ato loss- and gain-of-function analyses suggest a decisive
role in tumor formation in the ﬂy retina. The growth of
tumors is a balance between cell proliferation and cell death.
We asked whether ato regulates either or both of these
processes in the context of eyeful tumors, during the
development of these tumors. To this end, we examined
third instar larval eye discs, the Drosophila eye anlage, for
markers of apoptosis and proliferation. Overexpression of
Ato in the eyeful ﬂy results in dramatically increased levels of
the apoptotic regulator caspase-3 (FlyBase ID: FBgn0028381)
in eyeful eye discs (3-fold, p ¼ 0.011; Figure 2A–2D). This
explains, at least in part, the suppression of the eyeful tumors
in the adult ﬂies.
Next, we examined proliferation in eyeful eye discs under
gain and loss of ato function conditions, using phospho-
HistoneH3 (FlyBase ID:FBtr0071345) as a marker. Prolifer-
ation in the third instar eye disc normally occurs anterior to
the morphogenetic furrow, where all the cells are still
undifferentiated. Additionally, approximately two rows of
undifferentiated cells posterior to the furrow, called the
second mitotic wave (SMW), also proliferate. In the eyeful
discs, proliferating cells are not restricted to these two
domains but are also present posterior to the SMW (Figure
2E). Expression of ato in the eyeful disc reduces this ectopic
proliferation (Figure 2F), whereas inhibition of ato activity
increases ectopic proliferation (Figure 2G). As suppression of
Ato activity can initiate de novo tumor formation in a
sensitized background, we examined proliferation upon
expression of Ato
ERD in the Dl-sensitized background. In the
sensitized eye discs, proliferating cells are mostly restricted
anterior to the furrow and the SMW (Figure 2H), whereas loss
of ato function leads to the appearance of proliferating cells in
the posterior region of the disc (Figure 2I).
The total number of cell divisions in a tissue determines
the overall size of that tissue. We therefore quantiﬁed the
total number of phospho-HistoneH3–positive cells per disc.
Overexpression of Ato in eyeful eye discs results in a
signiﬁcant decrease in number of cells expressing the mitotic
marker phosphorylated HistoneH3 (p ¼ 0.00004; Figure 2J).
Conversely, expression of the dominant-negative Ato
ERD
leads to a signiﬁcant up-regulation of proliferation in the
eyeful eye discs (p¼0.004; Figure 2J). Thus, Ato limits number
of cell divisions in the eyeful tumors. Expression of Ato
ERD in
the Dl-sensitized eye discs results in a signiﬁcant increase in
phosphorylated HistoneH3 expression in the developing eye
discs (p¼0.002; Figure 2J), explaining the induction of tumors
by loss of ato.
Our analysis suggests that ato regulates both proliferation
and death of retinal precursors during tumor formation in
the Drosophila eye.
Ato Regulates Tissue Differentiation and Patterning in
Drosophila Eye Tumors
During normal development, Ato is required for the
correct differentiation of retinal cells and the proper
patterning of the eye disc. If Ato’s function in suppressing
eye tumors is related to its activity as a differentiation factor,
we might expect to observe Ato-dependent alterations in
tissue differentiation and organization upon manipulation of
Ato activity in a tumor context. To test this prediction, we
examined the expression of the early differentiation and R8
marker Senseless (Sens, CG32120), the general retinal photo-
receptor marker embryonic lethal, abnormal vision (ELAV,
CG4262), and the epithelial marker Armadillo/b-Catenin
(Arm, CG11579) following manipulation of Ato activity.
In wild-type and Dl-sensitized eye discs Arm, ELAV, and
Sens reveal the regular and stereotypical differentiation and
epithelial organization of the developing retina, although the
Dl-sensitized discs are clearly larger (Figure 3A and 3B). Loss
of Ato activity in the Dl-sensitized eye discs (Figure 3C) results
in the disruption of the regular pattern of Arm expression,
suggesting defects in the organization of the retinal epithe-
lium. This is accompanied by severe reduction in Sens and
ELAV staining, suggesting lack of differentiated photo-
receptors. The proportion of undifferentiated to differ-
entiated cells is increased, indicating that the initial steps of
retinal differentiation, namely the speciﬁcation of the Ato-
dependent R8 cell, are compromised (Figure 3C, white
arrows). In some instances, lobes of proliferative and
undifferentiated tissue are observed in these eye discs (Figure
3C, open arrow), correlating with the appearance of tumors
in the adult ﬂies. In the eyeful eye discs, disorganization of the
epithelium as well as defects in the pattern of differentiated
cells are apparent (Figure 3D). Overexpression of Ato in the
eyeful eye discs restores both the size and all three markers to
essentially wild-type patterns of expression (Figure 3E),
explaining the appearance of normal adult eyes in this
background. Conversely, expression of Ato
ERD severely
disrupts retinal patterning and the expression pattern of all
three markers (Figure 3F). Differentiation markers are not
only reduced, but also appear in a highly disruptive pattern to
the extent that the morphogenetic furrow is difﬁcult to
discriminate (Figure 3F).
(I) Graph showing quantification of the tumor burden in the different genotypes. Dotted lines show the comparison used for statistical analysis. A single
asterisk (*) indicates p , 0.05; triple asterisks (***) indicate p , 0.001 as analyzed by the chi-square test, and ‘n’ represents number of flies analyzed.
(J and K) Examples of metastasis and loss of differentiated eye tissue in eyeful and sensitized flies upon loss of ato function. (J) ey-GAL4, UAS-Dl, eyeful/
UAS-ato
ERD: black arrow shows metastasis, open arrow shows loss of differentiated eye tissue. (K) ey-Gal4, UAS-Dl/
þ, UAS-ato
RNAi/
þ with metastasis on
the head.
(L and L9) ey-Gal, UAS-Dl/UAS-ato
ERD showing metastasis in the thorax (black arrows) and on the head and loss of differentiated retina (open arrow).
(M) ey-Gal, UAS-Dl/UAS-ato
ERD showing a massive undifferentiated tumor (dotted line) on the fly head.
doi:10.1371/journal.pbio.1000040.g001
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sophila support a critical and early role for the loss of ato in
tumor initiation and progression. This effect is likely
mediated by alteration in the expression of downstream
genes required for retinal differentiation, as such perturbing
proliferation, apoptosis, and tissue organization.
Ato Functions via JNK-Dependent Mechanism
To better understand the role of that Ato plays in tumor
formation, we sought to determine the genetic mechanism by
which it acts to suppress the formation and progression of
tumors. Gain- and loss-of-function analysis indicated an ato-
dependent regulation of proliferation in the Drosophila eye.
Recently, the Drosophila ortholog of the gene encoding the cell
cycle inhibitor p21
waf1, dacapo (dap, CG1772), was reported to
be a target gene of ato in the eye [19]. Consistent with this,
overexpression of wild-type ato in the eye disc leads to
signiﬁcant up-regulation of Dap mRNA (;80%, p ¼ 0.018),
whereas expression of Ato
ERD leads to signiﬁcant down-
regulation of Dap mRNA (28%, p ¼ 0.014; Figure 4A). Ato
expression also results in earlier onset and elevated Dap levels
in the eyeful and wild-type eye discs, in agreement with the
reduction in pH3 levels observed in the same discs (Figures
4B–4D and S3).
We have shown that Ato regulates apoptosis and that it
restores proper differentiation in the eyeful eye discs. We
reasoned that tumorous eyeful cells may interpret the Ato
differentiation signal as cellular stress and, as a result, commit
suicide. A major regulator of cell death in response to stress is
the JNK pathway. We therefore examined the expression of
phosphorylated (i.e., activated) form of the Drosophila JNK
Figure 2. Apoptosis and Proliferation upon ato Loss and Gain of Function
(A–C) Staining for cleaved caspase-3 indicates an increase in apoptosis upon overexpression of ato in the eyeful flies. (A) Immunohistochemistry for
cleaved capsase-3 in wild type.
(B) Cleaved caspase-3 staining in ey-GAL4, UAS-Dl, eyeful/
þ.
(C) ey-GAL4, UAS-Dl, eyeful/UAS-ato.
(D) Quantification of cleaved caspase-3–positive cells per eye disc. Error bars indicate the standard error of the mean, and double asterisks (**) indicate p
, 0.05.
(E–I) Representative images from third instar eye discs in different genetic backgrounds stained for phospho-Histone H3 (P-H3). (E) ey-GAL4, UAS-Dl,
eyeful/
þ. (F) ey-GAL4, UAS-Dl, eyeful/UAS-ato. (G) ey-GAL4, UAS-Dl, eyeful/UAS-ato
ERD. (H) ey-GAL4, UAS-Dl/
þ. (I) ey-GAL4, UAS-Dl/UAS-ato
ERD. (J)
Quantification of proliferating cells in the eyeful and sensitized background upon loss or gain of ato function. Quantification was done for a minimum of
ten eye discs per genotype. The chi-square test was used to analyze for significance. Dotted lines connect compared genotypes. Triple asterisks (***)
indicate p , 0.001; double asterisks (**) indicate p , 0.01.
doi:10.1371/journal.pbio.1000040.g002
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Atonal Is a Tumor Suppressor GeneFigure 3. Analysis of Tissue Patterning and Differentiation in Third Instar Eye Discs
Immunohistochemistry was used for armadillo (arm, green), embryonic lethal, abnormal vision (elav, blue), senseless (sens, red), and
diamidinophenylindole (dapi, grey)
(A) Wild-type eye disc.
(B) ey-GAL4, UAS-Dl/
þ shows enlarged discs with wild-type patterning.
(C) ey-GAL4, UAS-Dl/UAS-ato
ERD show disrupted patterning with expansion of the undifferentiated domain (white arrows). Proliferative outgrowth is
indicated with an open arrow.
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Atonal Is a Tumor Suppressor Gene(pJNK), Basket (Bsk, CG5680). Eyeful discs show reduced
pJNK levels. Overexpression of Ato in this background, as
well as wild-type eye discs, results in dramatic up-regulation
of pJNK levels (Figures 4B–4D and S3).
These data suggest that Ato regulates the expression and
activity of major regulators of cell proliferation and death.
We therefore tested whether these genes also play a role in
the eyeful tumors. Dap overexpression leads to a signiﬁcant
inhibition of tumor occurrence (22%, p , 0.0001, n ¼ 107;
Figure 5C and 5I), but only a partial reduction in metastasis
(1%, p ¼ 0.1145). Thus, whereas Dap regulation appears to
contribute to tumor suppression by Ato, it is unlikely to
explain the full effect of ato expression.
To analyze whether the elevated activity of JNK signaling
upon ato expression is functionally relevant, we inhibited JNK
signaling using a dominant-negative form of Bsk (Bsk
DN). This
partially mimics down-regulation of ato in the eyeful model
and results in tumors in 61% of the eyes (p¼0.574; Figure 5D
and 5I) and an approximately7-fold increase in metastasis (p¼
0.0003). Furthermore, expression of Bsk
DN in the Dl-
sensitized background leads to the induction of tumors
(2%, p ¼ 0.0113, n ¼ 57; Figure 5H and 5I) and metastasis
(3.5%, p ¼ 0.0112). Conversely, overexpression of Djun (Jra,
CG2275), the transcriptional effector of the JNK pathway,
leads to reduction of the tumor burden (38% tumors, p ¼
0.0036, n ¼ 40; 0% metastasis, p ¼ 0.559; Figure 5F and 5I),
partially mimicking overexpression of Ato expression.
Next, we tested genetic epistasis between ato and JNK by
overexpressing Ato while simultaneously inhibiting JNK
signaling. This leads to a suppression of the inhibitory effects
of ato on the eyeful ﬂies and restores tumor formation (48%, p
, 0.001), as well as enhances the metastatic phenotype (15%,
p ¼ 0.001, n ¼ 27; Figure 5E and 5I). This indicates that JNK
signaling is downstream of ato and that ato requires active JNK
signaling to inhibit cancer formation.
Discussion
Our data support a function for ato in oncogenesis. Loss of
ato promotes tumor formation and progression and might, as
such, be selected for during oncogenesis. This indicates that
tumor formation and progression might not only require
maintenance of self-renewal capacity, but also loss of the
capacity to induce cell fate commitment and differentiation.
Therefore, genes that act precisely at the junction of the
transition from a proliferating progenitor to a committed
cell ought to show anti-oncogenic behavior. Losing ato in the
Figure 4. Ato Up-Regulates Dap and p-JNK
(A) Quantitative RT-PCR for Ato (first two bars) and Dap (second two bars) upon Ato (white bars) and Ato
ERD (gray bars) expression, standardized to wild
type and driver controls and to expression of three housekeeping genes. Error bars indicate the standard error of the mean. Double asterisks (**)
indicate p , 0.01 (t-test).
(B–D) Expression of ato in ey-GAL4, UAS-Dl, eyeful flies up-regulates Dap and phosphorylated JNK. (B) Third instar eye disc from wild type. (C) Third instar
eye disc from ey-GAL4, UAS-Dl, eyeful/
þ. (D) Third instar eye discs from ey-GAL4, UAS-Dl, eyeful/UAS-ato. A indicates anterior; P indicates posterior.
doi:10.1371/journal.pbio.1000040.g004
(D) ey-GAL4, UAS-Dl, eyeful/
þ.
(E) Gain of ato function in the eyeful background leads to restoration of the pattern of differentiation: ey-GAL4, UAS-Dl, eyeful/UAS-ato shows almost
normal appearance of all markers.
(F) Loss of ato function in an eyeful background leads to loss of uniform arm staining and a loss of and abnormal pattern of differentiation (elav and
sens, white arrows). ey-GAL4, UAS-Dl, eyeful/UAS-ato
ERD.
Images and orthogonal sections are shown. All images were taken at the depth of the nuclei. Scale bars represent 100 lm.
doi:10.1371/journal.pbio.1000040.g003
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Atonal Is a Tumor Suppressor Geneabsence of any other compounding factor is neutral towards
tumor formation. However, loss of ato in a sensitized
background is sufﬁcient to initiate and enhance tumor
formation. In our experiments, we used activation of the
Notch signaling pathway as a sensitizing factor, but other
pathways also lead to the formation of tumors when ato is lost
[13]. Therefore, loss of differentiation factors might ‘‘tip the
balance’’ towards malignancy, regardless of what the addi-
tional oncogenic event may be. It will be interesting to
investigate what the different pathways are that interact with
loss of ato to enhance cancer formation and how they switch
an ato mutation from neutral to tumor progression to
oncogenic.
The induction of cellular differentiation acts on two levels:
ﬁrst, the cell cycle is inhibited by the expression of cell cycle
inhibitors; and second, gene expression is modulated to
instruct a speciﬁc fate and function. Several lines of evidence
suggest that both levels of ato activity are important in its
anti-oncogenic function. First, ato regulates the expression of
dap—itself a direct target gene of ato during normal differ-
entiation—during eye tumor formation. Second, loss of ato
leads to more proliferation in the sensitized and cancerous
tissue in a Drosophila model. Third, loss of ato leads to the
disruption of retinal differentiation and patterning, correlat-
ing with the formation of tumors that include overgrowth of
undifferentiated tissue in the ﬂy eye. Together, these data
support the idea that Ato exerts its anti-oncogenic function
by activation of its developmental target genes and pathways.
Finally, earlier reports suggest that, under certain conditions,
proliferation can be uncoupled from the induction of
differentiation as double-mutant cells for retinoblastoma and
dacapo in the developing Drosophila eye keep proliferating
although they start to differentiate [20]. Our data suggest that
the inhibition of proliferation is not the only mechanism by
which differentiation factors might suppress tumor forma-
tion, as ato is also able to induce apoptosis in an eyeful eye
disc.
The function of JNK in the Drosophila eye has been
described as both tumor promoting and anti-oncogenic.
Igaki and colleagues describe a role for JNK in invasion upon
loss of cell polarity [21], and Uhlirova et al. describe how JNK
cooperates with Ras to induce tumor overgrowth in the eye
Figure 5. ato Functions by a JNK-Dependent Mechanism
(A) ey-GAL4, UAS-Dl, eyeful/
þ fly.
(B) ey-GAL4, UAS-Dl, eyeful/UAS-ato.
(C) ey-GAL4, UAS-Dl, eyeful/UAS-dap.
(D) bsk
DN/X; ey-GAL4, UAS-Dl, eyeful/
þ.
(E) ato function depends on JNK activity: bsk
DN/X; ey-GAL4, UAS-Dl, eyeful/UAS-ato.
(F) ey-GAL4, UAS-Dl, eyeful/UAS-Djun.





(I) Quantitative representation of the tumor burden in different genotypes. Each lane is a separate genotype. Gray bars show percentage of tumorous
eyes; pie charts give metastasis incidence. Double asterisks (**) indicate p , 0.01; triple asterisks (***) indicate p , 0.001 as analyzed by chi-square test,
and n represents number of flies analyzed.
doi:10.1371/journal.pbio.1000040.g005
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cells, however, JNK is necessary to remove these cells by
apoptosis [22]. This shows that the molecular environment in
which JNK acts decides the outcome. We propose that the
status of differentiation might be an important factor in the
decision of the outcome of JNK activity. ato function might
divert JNK from an oncogenic function to a tumor suppressor
function in which JNK will reduce the size of the overgrowth
and, as such, reduce the number of metastases. Our data
indicate that although JNK is necessary for the anti-
oncogenic function of Ato, it is not sufﬁcient, because
inhibition of JNK signaling does not completely mimic the
loss of ato function in the eyeful ﬂies. This suggests JNK as a
permissive, rather than instructive, factor for ato’s function
and indicates that ato might also modulate tumor formation
by JNK-independent mechanisms.
In summary, we present the ﬁrst evidence that a master
regulator of tissue-speciﬁc differentiation is a key regulator
of tumor initiation and progression. The evidence that the
human ortholog of Ato is a tumor suppressor gene in
colorectal cancer, the largest cause of cancer deaths world-
wide [13], as well as the absolute functional conservation
between ﬂy and mouse Ato [23] underscore the importance of
understanding the fundamental molecular and genetic
mechanisms of the function of this group of key devel-
opmental regulators.
Materials and Methods
Drosophila husbandry. Fly strains used were ey-GAL4, GS88A8, UAS-
Dl/Cyo (called eyeful ﬂies in the text) and ey-GAL4, UAS-Dl/Cyo ﬂies (a
gift from M. Domiguez), UAS-ato
RNAi3B and UAS-ato
RNAi 4E (gift from
A. P. Jarman), UAS-ato, UAS-Atoh1, w1118 PfUAS-bsk.DNg2, UAS-Djun,
UAS-dacapo (a gift from A. Hidalgo), CantonS, and yw. All ﬂies were
raised at 25 8C on standard ﬂy food.
Immunohistochemistry. Eye discs of wandering third instar larva
were dissected and processed as described [24]. ato antibody (kind gift
fromA.Jarmanand P.zurLage), Dapantibody(DevelopmentalStudies
Hybridoma Bank), P-JNK (Cell Signaling Technologies), phospho-
HistoneH3 (Upstate Biotechnologies), and cleaved caspase-3 (Cell
Signaling Technology).
Generation of UAS-ato
ERD transgenic ﬂies. Uas-ato
ERD was generated
by fusing the full-length Atonal ORF to a fragment encoding a Myc-
tagged Engrailed repression domain (amino acids 2–298) [25] using
the pUAST vector [26]. Seven uas-ato
ERD transgenic lines were
obtained using standard Drosophila transformation protocols.
Quantitative reverse-transcriptase PCR on Drosophila larval eye-
antennal discs. Crosses between ato-GAL4 (PfGawBgNP6558 obtained
from Drosophila Genetic Resource Center, Kyoto) or Gal4–7 and UAS-
ato or UAS-ato
ERD were performed at 18 8C and shifted to 28 8Ca t
third larval instar stage. Eye-antennal discs were dissected in RNA
later (Ambion). RNA extraction was performed with Mini RNA
Isolation kit (Zymo Research). act79B, gadph, and Rpl32 were used as
control housekeeping genes (DCT), and Canton S and UAS-Ato as
control RNA (DDCT).
Image quantiﬁcation of proliferating and apoptotic cells. The
number of proliferating cells per eye disc was quantiﬁed using the
‘‘analyse particle’’ function in ImageJ with the parameters 5 to 60 for
size and 0.5 to 1.0 for circularity.
Supporting Information
Figure S1. Outgrowth Originates from the Eye Disc Proper
(A) Third instar eye disc of ey-Gal4.Dl.eyeful/
þ. Confocal section of
antibody-stained eye disc for senseless (red; indicating R8 photo-
receptors), armadillo (green; indicating cell cortexes), and elav (blue;
marker of mature neurons). Respective z-stacks are indicated next to
the main image. White line indicates normal outline of eye-antennal
imaginal disc. The malignant outgrowth (striped square) is enlarged
in (B).
(B) Enlarged image from (A). Respective z-stacks are indicated next to
the main image. White arrowhead indicates morphogenetic furrow in
eye disc outgrowth. The different cell types present in a normal eye
are also present in the outgrowth, indicating that the outgrowth
originates from undifferentiated normal eye disc tissue.
Found at doi:10.1371/journal.pbio.1000040.sg001 (4.60 MB PDF).
Figure S2. Adult Loss of Phenotypes of Loss of ato Function
(A) Representative picture ey-Gal4.
(B) Representative picture of UAS-ato
RNAi driven by ey-Gal4. ato
RNAi
construct is active since the expression in the developing eye leads to
a decrease in eye size.
(C) Representative picture of UAS-ato
ERD driven by ey-Gal4. The ato
ERD
leads to a phenocopy of the loss of ato.
Found at doi:10.1371/journal.pbio.1000040.sg002 (378 KB PDF).
Figure S3. Ato, Dap, and pJNK Expression in Wild-Type Eye Discs
Expression of ato in wild-type ﬂies up-regulates Dap and phosphory-
lated JNK. Third instar eye disc from eyeless-Gal4/UAS-ato is shown.
Found at doi:10.1371/journal.pbio.1000040.sg003 (2.06 MB PDF).
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